Introducing the International Centre for Genomic Medicine in Neuromuscular Diseases (ICGNMD)

The International Centre for Genomic Medicine in Neuromuscular Diseases (ICGNMD) is a £5 m, 5 year MRC Strategic award whose goal is to improve health outcomes for people with neuromuscular diseases (NMDs) globally. Activity is distributed across 14 Centres in Brazil, India, Turkey, South Africa, the United Kingdom and Zambia. The ICGNMD aims to: • deliver an international genomics research & capacity-building partnership in genomic medicine; • facilitate international NMD patient access to accurate genetic diagnoses; • assemble “trial ready” comprehensively phenotyped and genotyped cohorts of people living with NMDs and their families; and growing clinical capacity in neuromuscular diseases by training a cohort of clinical academic researchers.